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Aldosterone production during dietary sodium restriction and beta-
adrenergic blockade. The role of the renin-angiotensin system in
mediating the aldosterone response to sodium depletion was ex-
amined by administration of propranolol during dietary sodium
restriction, The beta-adrenergic antagonist prevented the expected
increase of plasma renin activity in response to sodium restriction
in six of twelve studies. Plasma angiotensin I! concentration failed
to increase in four of five subjects in whom the renin response was
abolished. Despite unchanged or decreased plasma renin activity
and plasma angiotensin II concentration, plasma aldosterone con-
centration increased significantly in response to dietary sodium
restriction. The increase in aldosterone production could not be
attributed to changes in plasma sodium or potassium concentra-
tion or increased ACTH secretion. It is suggested that the aldoste-
rone response to sodium restriction is mediated not only by in-
creased plasma renin activity and angiotensin II concentration, but
also by another mechanism, possibly related to increased adrenal
sensitivity to angiotensin during sodium depletion.
Production d'aldostérone au cours de Ia restriction de sodium
alimentaire et de l'administration de beta-bloquants. Le role du
système rénine-angiotensine dans Ia mediation de Ia réponse de Ia
secretion d'aldostérone a Ia dCplétion en sodium a été étudié au
moyen de l'administration de propranolol au cours de Ia restriction
de sodium alimentaire. Le beta-bloquant empêche l'augmentation
de l'activité rénine plasmatique en réponse a Ia restriction de
sodium au cours de six sur douze des etudes ainsi conduites. La
concentration plasmatique d'angiotensine II n'a pas augmenté
chez quatre des cinq sujets chez lesquels Ia réponse de Ia rCnine
était abolie. Malgré l'activité rénine plasmatique et Ia concentra-
tion plasmatique d'angiotensine II inchangCes ou diminuées Ia
concentration plasmatique d'aldostérone a augmenté signifi-
cativement en réponse a Ia restriction du sodium alimentaire.
L'augmentation de Ia production d'aldostérone ne peut pas être
attribuée a des modifications des concentrations plasmatiques du
sodium ou du potassium ou a une augmentation de Ia secretion
d'ACTH. II est suggéré que Ia réponse de I'aldostérone a Ia restric-
tion du sodium a pour médiateur non seulement I'augmentation de
l'activité rénine plasmatique et de La concentration d'angiotensine
II mais aussi un autre mécanisme qui pourrait ètre lie a une
augmentation de La sensibilité de La surinale a l'angiotensine au
cours de La déplétion en sodium.
The commonly held view that the renin-angioten-
sin system is the major factor in the control of al-
dosterone production rests, in large part, on the dem-
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onstration that acute infusions of angiotensin II
stimulate aldosterone production [1, 2], on the con-
cordant changes in plasma renin activity and aldoste-
rone production observed during dietary sodium de-
pletion [3—5], and on the parallel diurnal variations in
plasma renin activity and plasma aldosterone concen-
tration in normal subjects on unrestricted or low
sodium intake [6].
During the past several years, each of these lines of
evidence has been subjected to reexamination. McCaa,
McCaa, and Guyton [7] confirmed that angio-
tensin II infusion in the dog resulted in an acute
increase in aldosterone production, but found that
angiotensin II failed to produce sustained increase in
aldosterone production. Blair-West et al found that
while angiotensin II infusion stimulated aldosterone
production in sheep, neither renin nor angiotensin II
infusion was as effective in this regard as sodium
depletion [8]. Discordant changes in plasma renin
activity and aldosterone production during sodium
depletion have been observed (or could be induced)
in experimental animals and in man. Blair-West et al
found that plasma aldosterone fell before plasma re-
nm activity during rapid replacement of sodium in
sheep made sodium-deplete by drainage of a parotid
fistula [9], and later reported that suppression of
plasma renin activity by intrarenal infusion of angio-
tensin II did not prevent the expected rise in plasma
aldosterone during acute sodium depletion [10].
Fichman, Michelakis, and Horton reported that
patients with inappropriate secretion of antidiuretic
hormone (ADH) and normal volunteers receiving
exogenous ADH and increased water intake were
able to increase aldosterone production appropri-
ately in response to sodium deprivation despite per-
sistent suppression of plasma renin activity [11]. Best
et al found that plasma aldosterone concentration in
normal man increased without significant change in
angiotensin II concentration after three days of
dietary sodium restriction [12], and although Boyd et
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al did observe increased angiotensin II following a
longer period of sodium restriction, they concluded
that the increase was insufficient to account for the
observed increase in plasma aldosterone concentra-
tion [13]. Weinberger et al found discordant diurnal
changes in plasma renin activity and plasma aldoste-
rone concentration in recumbent normal subjects and
concluded that another factor might be important in
controlling aldosterone production [14]. In summary,
while it appears well established that the renin-angio-
tensin system is capable of stimulating aldosterone
production, the role of angiotensin II in mediating
the aldosterone response to sodium depletion is open
to question.
We have attempted to examine the role of the
renin-angiotensin system in mediating the aldoste-
rone response to dietary sodium restriction in man,
making use of the observation by Michelakis and
McAllister that beta-adrenergic blockade can prevent
the rise in plasma renin activity usually seen in re-
sponse to low sodium diet [15].
Methods
Studies were carried out in nine, normal volunteers
and two patients with mild essential hypertension.
Two normal subjects were studied in the Clinical
Research Center of Bellevue Hospital Center; the
remainder, medical staff members, were studied on
an ambulatory basis. One hypertensive patient was
studied in the hospital following an admission for
diagnostic studies; the other was studied as an out-
patient. All subjects were informed as to the nature of
the procedures and the purpose of the investigation
before entering the study.
Baseline measurements of plasma renin activity
(PRA), plasma angiotensin II concentration (A-lI),
plasma aldosterone concentration (PAC), and plasma
cortisol concentration were made while the subject
was on an ad jib diet and taking no medication.
Followingthese baseline measurements, each subject
was instructed to follow a diet estimated to contain
no more than 25 mEq of sodium daily and was given
160 mg of propranolol daily in four divided doses;
one subject, no. 5, was restudied while receiving 320
mg of propranolol daily. Six subjects (no. 1 to 6) were
also studied under a protocol which was identical to
that described above except for the omission of pro-
pranolol.
Daily 24-hr urine collections were made, both on
the day of the baseline measurements (ad jib diet)
and throughout the seven days of dietary sodium
restriction. Venous blood samples were obtained af-
ter one hour of recumbency, between 8 and 9 AM,
before (baseline) and following one week of dietary
sodium restriction with or without propranolol ad-
ministration.
Plasma renin activity and angiotensin II concentra-
tion were measured by the method of Boyd et al [16,
17]. Plasma aldosterone concentration was measured
by radioimmunoassay following paper chromatogra-
phy by a modification of the method of Mayes et al
[18]. Plasma cortisol and urinary free cortisol were
measured by competitive binding radioassay [19]. So-
dium and potassium in plasma and urine were mea-
sured by flame photometry.
For purposes of data analysis, we have grouped
those subjects in whom plasma renin activity in-
creased following dietary sodium depletion and ad-
ministration of propranolol (subjects 1 through 5)
and those in whom plasma renin activity was un-
changed or fell following sodium depletion and pro-
pranolol (subjects 6 through 11), and compared the
changes in plasma aldosterone in these groups with
those observed following dietary sodium depletion
alone. Evaluation was performed using Student's t
test as applied to unpaired or paired data. See Appen-
dix for discussion of an alternative statistical ap-
proach.
Results
In 18 baseline studies of subjects on ad jib diet and
six studies of subjects during sodium restriction with-
out propranolol (Table 1, 2, Fig. I), plasma renin
activity (PRA) varied inversely with 24-hr sodium
excretion as described previously by Laragh et al [20].
Plasma aldosterone concentration similarly was
found to vary inversely with urinary sodium excre-
tion (Fig. 2). In the six subjects (no. 1 through 6)
studied following one week of dietary sodium restric-
tion without propranolol administration, urinary so-
dium excretion fell to 21 mEq/24 hr (range, 13 to 29
mEq/24 hr) and plasma renin activity increased sig-
nificantly in all (Table 1, Fig. 1). PRA averaged 260
pg/mi/hr in subjects on an unrestricted diet and in-
creased to a mean of 960 pg/ml/hr after sodium
restriction. This almost fourfold increase in PRA
during sodium restriction is comparable to that re-
ported by others [4]. As shown by the dashed lines
connecting points obtained in the same subject (Fig.
1), the magnitude of the increase in PRA during
sodium deprivation correlated closely with the mag-
nitude of the change in sodium balance. Plasma a!-
dosterone concentration increased in five subjects
and was unchanged in one; plasma aldosterone con-
centration on unrestricted diet averaged 5.7 ng/dl,
and during sodium restriction, 23.4 ng/dl (Table 1).
In 11 studies, subjects received 160 mg of pro-
pranolol in four divided doses throughout the period
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Table 1. Effects of dietary sodium restriction in normal subjeetsa
Unrestricted diet Low sodium diet
Urinary Plasma Plasma Urinary Plasma Plasma
Subject PRA PAC Na K Na K cortisol PRA PAC Na K Na K cortisol
no. pg/mi/hr ng/di mEq/24 hr mEq/iiter j.ig/di pg/mi/hr ng/dI mEq/24 hr mEq/iiter ig/di
1 620 12.8 143 42 138 3.9 7.7 1,050 46.0 24 85 146 4.4 10.8
2 60 1.1 246 100 142 4.0 10.0 910 20.3 23 104 137 4.3 12.4
3 130 2.7 368 97 140 4.4 9.0 1,370 34.8 13 59 139 4.9 10.0
4 400 6.0 270 98 139 4.6 10.8 1,250 26.8 14 75 139 4.3 16.2
5 160 2.2 75 83 143 4.1 — 450 4.4 29 75 142 3.8 16.4
6 190 9.3 188 75 142 3.9 7.4 730 8.2 24 85 138 3.6 7.5
Mean 260 5.7 215 83 141 4.2 9.0 960b 234b 2l 81 140 4.2 122b
S}M 90 1.9 42 9 I 0.1 0.7 140 6.5 3 6 1 0.2 1.4
a Abbreviations used: PRA = plasma renin activity; PAC = plasma aldosterone concentration.
P < 0.05 by paired t test regular diet vs. low sodium diet.
of dietary sodium restriction; one subject was Fe- in response to low sodium diet alone (P <0.05). PRA
studied while receiving 320 mg of propranolol daily fell or was unchanged in six subjects (6 through 11),
(Table 2, Fig. 3). In five subjects (no. 1 through 5), averaging 430 180 pg/mI/hr before and 220 40
PRA increased during dietary sodium restriction de- pg/mi/hr during dietary sodium depletion and pro-
spite concomitant propranolol administration; in a pranoiol administration. Plasma angiotensin II con-
second study in subject 5, PRA increased during so- centration was unchanged or fell in four of five sub-
dium restriction despite the administration of 320 mg jects in whom PRA response was suppressed during
of propranolol daily. The increase in PRA from a low sodium diet with propranolol and increased from
mean of 250 + 100 pg/mi/hr to 790 40 pg/mi/hr in 12 to 25 pg/mi in the remaining subject (no. 7).
subjects 1 through 5 during low sodium diet with Plasma angiotensin II concentration increased in
propranolol was significantly less than that observed three of four subjects in whom plasma renin activity
Table 2. Effects of propranolol on response to dietary sodium restrictiona
Unrestricted diet Low sodium diet—propranolol
PRA Plasma Urinary Plasma Plasma PRA Plasma Urinary Plasma Plasma
Subject pg/ini/ A-li PAC Na1 K Na K cortisol pg/mi/ A-Il PAC NaF K Na K cortisol
no. hr pg/mi ng/di rnEq/24 hr mEq/iiter g/di hr pg/mi ng/di mEq/24 hr mEq/llter g/di
I 710 14 15.3 137 51 141 3.8 5.7 880 33 39.8 5 60 143 4.0 8.5
2 210 55 3.7 124 90 141 4.5 12.8 640 49 11.8 9 64 136 4.9 12.6
3 100 11 2.0 373 85 143 4.4 8.9 800 26 25.3 24 56 136 4.5 18.0
4 150 — 6.5 234 65 140 4.3 9.6 910 54 22.1 15 67 140 3.8 11.1
5 40 17 2.1 162 89 139 4.1 11.4 780 18 7.3 15 40 138 3.9 12.2
5 260 ii 2.2 80 75 140 4.2 13.2 71Øb 16 9.9 14 63 139 3.9 17.4
6 260 15 6.8 98 81 147 4.1 6.4 170 8 12.8 23 79 140 3.8 11.9
7C 1,270 12 13.7 129 75 134 4.0 4.0 320 25 19.6 6 71 135 4.2 12.0
8" 80 14 10.9 182 52 138 4.2 12.9 60 15 18.8 61 27 141 5.6 12.0
9 490 16 7.1 172 47 143 4.7 7.2 310 13 14.8 19 60 142 4.4 24.4
10 160 17 4.8 239 133 137 4.4 17.0 190 10 6.9 21 58 140 4.6 9.2
ii 330 — 3.6 165 37 143 4.0 15.8 280 — 6.3 67 54 148 4.3 10.6
Mean,
subjects
1—5 250 22 5.3 185 76 141 4.2 10.3 790d 33 194d 14d 58 139 4.2 13.3
SEM tOO 8 2.1 43 6 1 0.1 1.2 40 7 5.0 3 4 1 0.2 1.5
Mean,
subjects
6—li 430 15 7.8 164 71 140 4.2 10.6 220e 14 13.2d.a 33d 58 141 4.5 13.4
SEM l80 I 1.6 20 14 2 0.1 2.2 40 3 2.3 10 7 2 0.3 2.3
a Abbreviations used: A-li = angiotensin 11; see Table 1 for other abbreviations.
b 320 mg of propranolol.
Hypertensive.
P < 0.05, regular diet vs. low sodium with propranolol by paired I test.
P < 0.05, change from unrestricted diet to low sodium diet with propranolol, subjects 1—5 vs. 6—11, by unpaired I test.
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1,400
sodium diet and propranolol. Plasma cortisol in-
creased in seven subjects and was decreased or un-
1 200 .0NNN changed in five. In paired comparison, the change inNN plasma cortisol was not significant. Urinary free cor-
,ooo - 0N N N tisol excretion, an index of adrenocorticotropic hor-\ N\ mone (ACTH) concentration integrated over a 24-hr
800 - N period, was measured in two subjects (6 and 7); in
0N N N both instances urinary free cortisol excretion was
. 600 found to decrease during sodium depletion.N" •
400 Discussion
•• N The present data demonstrate that the expected200 - \• • N increase in plasma renin activity during dietary so-
I I I' " I dium restriction can be prevented or significantly di-
50 100 150 200 250 300 350 400 minished by administration of the beta-adrenergic
Sodium excretion, mEq/24 hrs antagonist, propranolol. In the dog, renal denerva-
Fig. 1. Recumbent plasma renin activity during unrestricted (solid tion has been found to abolish [21] or to reduce [22,
symbols) and sodium restricted (open symbols) diet. The dashed 23] the renin response to sodium depletion, suggesting
lines connect values obtained in the same subject. that the renin response might be mediated through
adrenergic nerves to the kidney. Our observations are
consistent with the suggestion that the renin response
increased during dietary sodium restriction and pro- to sodium depletion in man is mediated through the
pranolol administration, sympathetic nervous system, but do not exclude the
Plasma aldosterone concentration increased during possibility that inhibition of renin release by beta-
sodium restriction and propranolol administration in adrenergic blockade simply offsets stimulation of re-
every instance, irrespective of whether renin in- nm release in response to sodium restriction mediated
creased (subjects 1 through 5) or did not increase through mechanisms independent of the sympathetic
(subjects 6 through 11). The increase in plasma al- nervous system. Other authors have examined the
dosterone concentration in subjects in whom PRA
increased during low sodium diet—propranolol (sub-
jects 1 through 5) averaged 14.1 ng/dl and was signif-
icantly less than that observed in subjects examined 50 -
during dietary sodium restriction alone (Table 1).
The increase in plasma aldosterone concentration in — \
subjects in whom the renin response was suppressed
40(subjects 6 through 11) averaged 5.4 ng/dl. While the
aldosterone response was significantly greater (P <
0.05) in subjects 1 through Sin whom PRA increased
than it was in patients 6 through 11, the increase in 30 -
plasma aldosterone concentration during dietary so-
dium restriction was highly significant (P < 0.02) in
both groups. Urinary sodium excretion fell below 25
mEq/day in all but two subjects and did not differ
significantly in subjects in whom PRA rose (subjects
1 through 5) and those in whom the renin response
was suppressed (subjects 6 through 11). Plasma so-
dium concentration was not significantly different
from control values following low sodium diet and
propranolol. Plasma potassium concentration fell in
five studies and increased in seven; the mean plasma
potassium on regular diet (4.2 mEq/liter) did not
differ from that following low sodium diet with pro-
pranolol (4.3 mEq/liter). Mean potassium excretion
fell from 73.1 mEq/liter to 58.3 mEq/liter during low
20
0
NN\N
°N \NNN NN\ N
N\ NN N
- N \,NNN NN 'N NN N
. SN •N N
- N •O. • • N
N,. I .I I
10
50 100 150 200 250 300 350 400
Sodium excretion, mEq/24 hrs
Fig. 2. Recumbent plasma aldosterone concentration during unre-
stricted (solid symbols) and sodium restricted (open symbols) diet.
The dashed lines connect values obtained in the same subject.
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propranolol orally; since the completeness of beta-
adrenergic blockade is related to the plasma concen-
tration of propranolol [26], this biologic variability
might have contributed to the heterogenous response
in our subjects.
Comparison of the aldosterone response to dietary
sodium restriction in subjects not receiving pro-
pranolol with the responses of subjects in whom pro-
pranolol diminished or completely prevented an in-
crease in PRA permits us to assess the contribution
of incresed circulating renin and angiotensin II and of
sodium depletion per se in stimulating aldosterone
production. The increase in plasma aldosterone con-
centration was greatest in the subjects in whom the
renin response was greatest, i.e., those not given
propranolol, less in the group in which propranolol
diminished the PRA response, and least, but still sig-
nificant, in the group in which PRA was unchanged
or fell. These responses are in accord with the known
correlation of renin activity and aldosterone secre-
tion; the nearly twofold increase in aldosterone when
PRA and angiotensin II did not increase allows the
further conclusion that other factors must also play a
1,200 0
E1000
800 20
C.,
600 150
400 10
200 50 i 0
Control Low sodium Control Low sodium
diet propranolol diet propranolol
Fig. 3. The response of PRA and plasma aldosterone Concentration to
dietary sodium restriction and propranolol. The solid lines in each
panel represent subjects #6-Il in whom the renin response to
sodium depletion was abolished by beta-adrenergic blockade.
renin response to sodium depletion in subjects who
were receiving propranolol for days to months prior
to the institution of dietary sodium restriction. The
data of Michelakis and McAllister suggest that while
PRA is lower during sodium restriction in subjects
receiving propranolol than in the same subjects dur-
ing dietary sodium restriction alone, PRA increased
in response to low sodium diet under both conditions
[15]. Bravo, Tarazi, and Dustan found that rapid
sodium depletion (low sodium diet and mercuhydrin)
resulted in an increase in PRA in hypertensive
patients who had been receiving propranolol for sev-
eral months [24]. The observation that renin respon-
siveness is not abolished in patients receiving
long—term propranolol treatment may be taken to
suggest that suppression of the renin response in our
studies represents the summation of the opposing
effects of beta-adrenergic blockade and sodium de-
pletion on renin release.
The finding that propranolol administration pre-
vented the renin response to dietary sodium restric-
tion in some subjects and only decreased the magni-
tude of the renin response in others might be
attributable to more complete beta-adrenergic block-
ade in the former group, but our observations do not
permit direct examination of this point. Resting
bradycardia was observed during propranolol admin-
istration in all subjects, but the degree of inhibition
of exercise-induced tachycardia, probably a better
quantitative measure of beta-adrenergic blockade,
was not examined. Plasma propranolol concentration
was not measured. Shand, Nuckolls, and Oates [25]
reported a sevenfold variation in plasma propranolol
concentration in normal subjects given 80 mg of
20
—
10
.
0.02 1 6X
0
I I
200 600 1,000 1,400
Plasma renin activity, pg ofangiotensin I/rn//hr
Fig. 4. The correlation of plasma aldosterone concentration with
plasma renin activity in subjects taking (open triangles, broken line;
N = 12, r = 0.435) and in those not taking (closed circles, solid line;
n = 24, r = 0.807) propranolol.
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role in the stimulation of aldosterone production dur-
ing sodium depletion.
Changes in plasma sodium during dietary sodium
restriction were not significant; changes in plasma
potassium concentration were small and inconstant
in direction, suggesting that potassium, a potent
agent in stimulating aldosterone production during
dietary [27, 28, 30] or intravenous potassium-loading
[7, 28, 29], was not responsible for increased aldoste-
rone production. The finding of unchanged plasma
cortisol and urinary free cortisol during sodium de-
pletion suggests that aldosterone secretion was not
stimulated by ACTH since, even during sodium de-
pletion, selective stimulation of the zona glomerulosa
by ACTH has not been observed [30]. Decreased
hepatic clearance of aldosterone probably contrib-
uted very little, if at all, to the observed increase in
plasma aldosterone concentration during sodium de-
pletion and propranolol, since dietary sodium deple-
tion does not appear to alter the metabolic clearance
rate of aldosterone in supine subjects [31, 32]. Fi-
nally, there is no evidence that propranolol acts di-
rectly to increase aldosterone production. Buhler et al
found that plasma aldosterone concentration fell in
hypertensive subjects given propranolol [33], and we
have made similar observations in patients given
propranolol without dietary sodium restriction (un-
published observations).
We cannot exclude the possibility that renin within
the adrenal [34] or bound to its surface membrane
might be affected by sodium depletion and mediate
local generation of angiotensin II and adrenal stimu-
lation, but the observation that aldosterone produc-
tion falls to low levels following nephrectomy in so-
dium-deplete sheep [35] makes the hypothesis that
aldosterone production is regulated by a wholly intra-
adrenal mechanism highly unlikely. Our finding
that aldosterone production is increased during
dietary sodium restriction despite suppression of
plasma renin activity and plasma angiotensin II con-
centration might, however, be explained by increased
adrenal sensitivity during sodium depletion. Hollen-
berg et al [4] and Oelkers et al [5] have reported
increased adrenal response to infused angiotensin II
during sodium depletion, but did not investigate the
mechanism responsible for increased adrenal sensi-
tivity. Recent evidence suggests that the hormonal
mediator of increased aldosterone production might
be the heptapeptide des-l-aspartyl All ("All!")
rather than the octapeptide, and that the steroid-
ogenic effect of angiotensin II may be mediated
through its conversion to the heptapeptide by adrenal
aminopeptidases [36—38]. It seems reasonable to
speculate that changes in aminopeptidase activity
could account for apparent changes in adrenal sensi-
tivity to infused or endogenous angiotensin II. Leary
and Ledingham found that angiotensin catabolism,
mediated in part by aminopeptidases, was enhanced
by sodium depletion [39]. If local generation of des-l-
asp A-I! is the rate-limiting factor in the regulation of
aldosterone production by the renin-angiotensin sys-
tem, enhanced aminopeptidase activity induced by
sodium depletion could account for increased adrenal
sensitivity and might provide an explanation for our
finding of increased aldosterone production in the
face of unchanged or decreased renin activity and
angiotensin II concentration during sodium restric-
tion and administration of propranolol.
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Appendix
In the text we have examined the increase of
plasma aldosterone concentration (PAC) during
dietary sodium restriction in three groups of subjects—
those not given propranolol, those given propranolol
in whom plasma renin activity (PRA) nonetheless
increased, and those given propranolol in whom
PRA failed to increase—and have found that in all
three the increase of PAC was significant. An alterna-
tive approach is to examine the correlation of PAC
with PRA in the presence or absence of propranolol.
One might expect that, if there is a stimulus to al-
dosterone release during low-sodium intake other
than the renin-angiotensin system, then to the extent
that the increase in PRA is suppressed by prop-
ranolol, the correlation of PRA with PAC would be
weaker.
Table 2 contains 24 pairs of PRA-PAC measure-
ments in the 11 subjects while not taking propranolol,
and 12 pairs in the same 11 subjects while taking
propranolol. Figure 4 presents a plot of these points
and the least-squares regression line of each group.
The correlation coefficient for the group not taking
propranolol, 0.807, differs significantly (P < 0.001)
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from zero, and that of the group taking propranolol,
0.435, does not (0.1 < P < 0.2). Although the corre-
lation is weaker in the group taking propranolol, the
difference in correlation coefficients is not significant
(0.1 < P < 0.2).
The difficulty with this approach lies partly in the
application of correlation and regression analysis,
which depends heavily on the assumption of a linear
relationship. Even a complete absence of correlation
for a limited range of the independent variable may
be obscured by including points from a more ex-
tended range over which the correlation is strong.
One might have predicted that the subjects whose
PRA did not increase during low salt diet on pro-
pranolol would generate points on the PAC-PRA
plot falling toward the left-hand side; as it happens,
they are represented by the six points furthest to the
left. Since there is no doubt that when PRA does
increase PAC tends to do so also, it is to be expected
that the six points furthest to the right will exhibit a
correlation of PAC with PRA. We have found a
correlation of PAC with PRA during propranolol
that is weaker than when propranolol was not given,
but not significantly weaker. Whether the correlation
of PAC with PRA in the entire group of patients is
somewhat weakened, significantly weakened, or to-
tally obliterated by propranolol is determined very
greatly, however, by the relative numbers of subjects
who display complete or only partial suppression of
PRA, and also, if there are (as here) some with only
partial suppression, by where their points happen to
lie on the PRA-axis. Analyzing the data in groups, as
we have in the Results section, permits use of the
simpler t tests; it also, and most importantly, elimi-
nates the need to assume a linear relation between
PRA and PAC which is implicit in the use of correla-
tion.
Reprint requests to Dr. Jerome Lowenstein, Dept. of Medicine,
New York University School of Medicine, 550 First Avenue, 11-440,
New York, New York 10016, U.S.A.
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